cardiovascular system

Impaired fasting glucose, type 2 diabetes mellitus, and lifetime risk of cardiovascular disease among women and men: the Rotterdam Study
Fariba Ahmadizar, Kan Wang, Elif Aribas, Lana Fani, Alis Heshmatollah, M Kamran Ikram, Maryam Kavousi

BMJ Open Diabetes Research and Care Aug 2021, 9 (1) e002406; DOI: 10.1136/bmjdrc-2021-002406
Casual blood glucose and subsequent cardiovascular disease and all-cause mortality among 159 731 participants in Cohort of Norway (CONOR)
Hilde Kristin Refvik Riise, Jannicke Igland, Gerhard Sulo, Marit Graue, Johannes Haltbakk, Grethe Seppola Tell, Marjolein Memelink Iversen

BMJ Open Diabetes Research and Care Feb 2021, 9 (1) e001928; DOI: 10.1136/bmjdrc-2020-001928
Serum calcification propensity is associated with HbA1c in type 2 diabetes mellitus
Rik Mencke, Amarens van der Vaart, Andreas Pasch, Geert Harms, Femke Waanders, Henk J G Bilo, Harry van Goor, Jan-Luuk Hillebrands, Peter R van Dijk

BMJ Open Diabetes Research and Care Feb 2021, 9 (1) e002016; DOI: 10.1136/bmjdrc-2020-002016
Glycemic variability and cardiovascular disease in patients with type 2 diabetes
Marcela Martinez, Jimena Santamarina, Adrian Pavesi, Carla Musso, Guillermo E Umpierrez

BMJ Open Diabetes Research and Care Mar 2021, 9 (1) e002032; DOI: 10.1136/bmjdrc-2020-002032
Trajectories in HbA1c and other risk factors among adults with type 1 diabetes by age at onset
Jon Edqvist, Araz Rawshani, Aidin Rawshani, Martin Adiels, Stefan Franzén, Lena Bjorck, Ann-Marie Svensson, Marcus Lind, Naveed Sattar, Annika Rosengren

BMJ Open Diabetes Research and Care May 2021, 9 (1) e002187; DOI: 10.1136/bmjdrc-2021-002187
Interplay between worsening kidney function and cardiovascular events in patients with type 2 diabetes: an analysis from the ACCORD trial
João Pedro Ferreira, Diana Ferrao, Patrick Rossignol, Faiez Zannad, Abhinav Sharma, Francisco Vasques-Novoa, Adelino Leite-Moreira

BMJ Open Diabetes Research and Care Jul 2021, 9 (1) e002408; DOI: 10.1136/bmjdrc-2021-002408
Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease
Odette S Reifsnider, Anuraag R Kansal, Pranav K Gandhi, Lael Cragin, Sarah B Brand, Egon Pfarr, Kyle Fahrbach, Anastasia Ustyugova

BMJ Open Diabetes Research and Care May 2021, 9 (1) e001313; DOI: 10.1136/bmjdrc-2020-001313
Trends in adherence to recommended physical activity and its effects on cardiometabolic markers in US adults with pre-diabetes
Xiaolin Qu, Kun Chen, Jigang Chen, Junhui Zhang

BMJ Open Diabetes Research and Care Sep 2022, 10 (5) e002981; DOI: 10.1136/bmjdrc-2022-002981
Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
Mahin Chowdhury, Sarah Nevitt, Aikaterini Eleftheriadou, Prathap Kanagala, Hani Esa, Daniel J Cuthbertson, Abd Tahrani, Uazman Alam

BMJ Open Diabetes Research and Care Dec 2021, 9 (2) e002480; DOI: 10.1136/bmjdrc-2021-002480
Adapted Diabetes Complications Severity Index and Charlson Comorbidity Index in predicting all-cause and cause-specific mortality among patients with type 2 diabetes
Yu-Wen Hu, Chiu-Mei Yeh, Chia-Jen Liu, Tzeng-Ji Chen, Nicole Huang, Yiing-Jenq Chou

BMJ Open Diabetes Research and Care Mar 2023, 11 (2) e003262; DOI: 10.1136/bmjdrc-2022-003262

Main menu

cardiovascular system

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

cardiovascular system

Pages